1Brenner BM, Cooper ME,de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcoms in patients with type 2 diabetes and nephropathy [J]. N Engl J Med, 2001,345 (12) : 861-869.
2Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensinreceptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes[J]． NEngl J Med,2001,345(12):851-860.
3Williams B, Gosse P,Lowe L, et al. The prospective, randomized in vestigation of the safety and efficacy of telmisartan versus ramipril using ambulatory blood pressure monitoring (PRISMAI) [J]. J Hypertens, 2006,24 (1) : 193-200.
